Precigen, Inc. (PGEN)
4.52
-0.14
(-3.00%)
USD |
NASDAQ |
Nov 13, 16:00
4.52
0.00 (0.00%)
After-Hours: 19:59
Precigen Gross Profit Margin (Quarterly) : 90.79% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 90.79% |
| June 30, 2026 | 94.32% |
| March 31, 2026 | 87.63% |
| December 31, 2025 | 58.07% |
| September 30, 2025 | 53.70% |
| June 30, 2025 | -64.72% |
| March 31, 2025 | -5.82% |
| December 31, 2024 | -24.96% |
| September 30, 2024 | -39.24% |
| June 30, 2024 | -209.9% |
| March 31, 2024 | -76.10% |
| December 31, 2023 | -109.0% |
| September 30, 2023 | -71.32% |
| June 30, 2023 | -43.94% |
| March 31, 2023 | -28.71% |
| December 31, 2022 | -37.15% |
| September 30, 2022 | 83.69% |
| June 30, 2022 | -51.87% |
| March 31, 2022 | 51.88% |
| December 31, 2021 | 22.26% |
| September 30, 2021 | 16.98% |
| June 30, 2021 | -8.47% |
| March 31, 2021 | 47.06% |
| December 31, 2020 | 28.67% |
| September 30, 2020 | 44.08% |
| Date | Value |
|---|---|
| June 30, 2020 | 50.99% |
| March 31, 2020 | 54.34% |
| December 31, 2019 | 9.36% |
| September 30, 2019 | 21.00% |
| June 30, 2019 | 49.08% |
| March 31, 2019 | 34.41% |
| December 31, 2018 | 66.03% |
| September 30, 2018 | 52.77% |
| June 30, 2018 | 59.06% |
| March 31, 2018 | 65.07% |
| December 31, 2017 | 80.06% |
| September 30, 2017 | 67.37% |
| June 30, 2017 | 69.05% |
| March 31, 2017 | 70.58% |
| December 31, 2016 | 69.11% |
| September 30, 2016 | 69.46% |
| June 30, 2016 | 67.46% |
| March 31, 2016 | 64.93% |
| December 31, 2015 | 63.95% |
| September 30, 2015 | 68.77% |
| June 30, 2015 | 59.31% |
| March 31, 2015 | 58.53% |
| December 31, 2014 | 47.96% |
| September 30, 2014 | 54.54% |
| June 30, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 61.57% |
| Aldeyra Therapeutics, Inc. | -- |
| Repligen Corp. | 48.44% |
| AC Immune SA | 0.00% |
| Inovio Pharmaceuticals, Inc. | -161.5% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 58.00% |
| Return on Assets | 14.37% |
| Return on Invested Capital | 17.38% |
| Profit Margin (Quarterly) | 48.24% |
| Operating Margin (Quarterly) | 52.13% |
| Return on Net Operating Assets | 27.10% |